▼ SELL
10b5-1 Plan
$ Value
$219K
Shares
8,000
Price
$27
Filed
Feb 6
Insider
Name
Cullivan Julie A
Title
—
CIK
0001713207
Roles
Director
Transaction Details
Transaction Date
2026-02-05
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
36,413
Footnotes
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
Filing Info
Cullivan Julie A's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | HTFL | ▼ | $228K |
| 2026-02-05 | HTFL | ▼ | $219K |
| 2025-08-07 | HTFL | A | $0 |
| 2025-05-29 | AXON | A | $0 |
Other Insiders at HTFL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BARABE TIMOTHY C | — | — | 2026-03-11 |
| HealthCor Partners Management LP | — | — | 2026-03-24 |
| Lightcap Jeffrey C | — | — | 2026-03-24 |
|
Rogers Campbell
Chief Medical Officer
|
— | $4.8M | 2026-04-01 |
| Bain Capital Life Sciences Investors, LLC | — | $56.1M | 2026-02-04 |
| Cullivan Julie A | — | $228K | 2026-03-05 |
|
Farquhar John C.M.
Chief Executive Officer
|
— | $1.8M | 2026-04-10 |
|
Jones Marie L.
Chief Accounting Officer, VP
|
— | — | 2026-02-06 |
|
Verghese Vikram
Chief Financial Officer
|
— | — | 2026-02-06 |